- Home
- TECH vs NICE Comparison
TECH vs NICE Comparison
Compare TECH & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- NICE
- Stock Information
- Founded
- TECH 1976
- NICE 1986
- Country
- TECH United States
- NICE Israel
- Employees
- TECH N/A
- NICE N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- NICE Computer Software: Prepackaged Software
- Sector
- TECH Health Care
- NICE Technology
- Exchange
- TECH Nasdaq
- NICE Nasdaq
- Market Cap
- TECH 8.2B
- NICE 8.6B
- IPO Year
- TECH 1989
- NICE 1996
- Fundamental
- Price
- TECH $60.60
- NICE $138.17
- Analyst Decision
- TECH Buy
- NICE Buy
- Analyst Count
- TECH 12
- NICE 13
- Target Price
- TECH $70.64
- NICE $204.46
- AVG Volume (30 Days)
- TECH 2.9M
- NICE 536.7K
- Earning Date
- TECH 10-29-2025
- NICE 11-13-2025
- Dividend Yield
- TECH 0.53%
- NICE N/A
- EPS Growth
- TECH N/A
- NICE 39.25
- EPS
- TECH 0.46
- NICE 8.36
- Revenue
- TECH $1,219,635,000.00
- NICE $2,838,467,000.00
- Revenue This Year
- TECH $3.97
- NICE $9.20
- Revenue Next Year
- TECH $7.81
- NICE $6.96
- P/E Ratio
- TECH $131.65
- NICE $16.54
- Revenue Growth
- TECH 5.23
- NICE 11.39
- 52 Week Low
- TECH $46.01
- NICE $127.00
- 52 Week High
- TECH $80.80
- NICE $200.65
- Technical
- Relative Strength Index (RSI)
- TECH 59.12
- NICE 41.70
- Support Level
- TECH $50.13
- NICE $134.22
- Resistance Level
- TECH $63.23
- NICE $141.10
- Average True Range (ATR)
- TECH 2.26
- NICE 3.78
- MACD
- TECH 0.76
- NICE -0.97
- Stochastic Oscillator
- TECH 65.25
- NICE 19.48
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.